Total Payments
$6,053
2024 Payments
$798.19
Companies
27
Transactions
416
Medicare Patients
868
Medicare Billing
$103,110
Payment Breakdown by Category
Food & Beverage$5,878 (97.1%)
Education$174.83 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,878 | 413 | 97.1% |
| Education | $174.83 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. | $681.50 | 29 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $642.94 | 52 | $0 (2024) |
| ABBVIE INC. | $640.30 | 49 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $573.64 | 28 | $0 (2023) |
| Lundbeck LLC | $445.08 | 27 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $424.65 | 33 | $0 (2023) |
| ITI, Inc. | $422.49 | 34 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $363.25 | 28 | $0 (2023) |
| Alkermes, Inc. | $226.17 | 15 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $225.45 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $798.19 | 41 | Supernus Pharmaceuticals, Inc. ($360.66) |
| 2023 | $1,769 | 116 | Vanda Pharmaceuticals Inc. ($293.88) |
| 2022 | $1,530 | 124 | Lundbeck LLC ($197.16) |
| 2021 | $1,956 | 135 | Teva Pharmaceuticals USA, Inc. ($264.12) |
All Payment Transactions
416 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| 09/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Insomnia | ||||||
| 09/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: PSYCHIATRY | ||||||
| 06/25/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: ADHD | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: PSYCHIATRY | ||||||
| 04/30/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: ADHD | ||||||
| 04/24/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 204 | 443 | $80,130 | $25,993 |
| 2022 | 4 | 191 | 545 | $97,410 | $32,875 |
| 2021 | 5 | 239 | 454 | $71,095 | $25,511 |
| 2020 | 7 | 234 | 347 | $63,375 | $18,730 |
Total Patients
868
Total Services
1,789
Medicare Billing
$103,110
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 295 | $59,000 | $18,520 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 97 | $14,550 | $4,962 | 34.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 22 | 22 | $5,550 | $2,430 | 43.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 26 | 29 | $1,030 | $81.50 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 445 | $89,000 | $30,271 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,950 | $1,555 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $2,700 | $849.44 | 31.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 42 | 67 | $1,760 | $199.97 | 11.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 206 | $41,200 | $14,270 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 161 | $24,150 | $8,907 | 36.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 15 | $3,750 | $1,978 | 52.7% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 44 | 57 | $1,425 | $180.73 | 12.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2021 | 15 | 15 | $570.00 | $175.80 | 30.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 108 | $21,600 | $6,927 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 68 | 116 | $17,400 | $4,748 | 27.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 40 | 40 | $10,000 | $2,941 | 29.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 23 | $5,750 | $1,492 | 25.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 30 | $4,500 | $1,399 | 31.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $3,750 | $1,185 | 31.6% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 14 | 15 | $375.00 | $38.83 | 10.4% |
About Brian Paugh, PA-C
Brian Paugh, PA-C is a Physician Assistant healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2014. The National Provider Identifier (NPI) number assigned to this provider is 1225430416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Paugh, PA-C has received a total of $6,053 in payments from pharmaceutical and medical device companies, with $798.19 received in 2024. These payments were reported across 416 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,878).
As a Medicare-enrolled provider, Paugh has provided services to 868 Medicare beneficiaries, totaling 1,789 services with total Medicare billing of $103,110. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Sioux City, IA
- Active Since 09/19/2014
- Last Updated 12/29/2015
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225430416
Products in Payments
- HETLIOZ (Drug) $681.50
- VRAYLAR (Drug) $640.30
- CAPLYTA (Drug) $604.42
- REXULTI (Drug) $503.36
- INGREZZA (Drug) $424.65
- Qelbree (Drug) $360.66
- AUSTEDO (Drug) $268.82
- QELBREE (Drug) $263.43
- ARISTADA (Drug) $226.17
- JORNAY PM (Drug) $194.32
- TRINTELLIX (Drug) $191.56
- SPRAVATO (Drug) $165.10
- QUVIVIQ (Drug) $150.17
- INVEGA SUSTENNA (Drug) $133.20
- LATUDA (Drug) $129.05
- Austedo XR (Drug) $119.96
- PERSERIS (Drug) $81.20
- Azstarys (Drug) $80.78
- BRINTELLIX (Drug) $74.18
- Dyanavel XR (Drug) $67.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Sioux City
Laurie Warren, P.a, P.A
Physician Assistant — Payments: $1,719
Physician Assistant $1,719
Colette Demoss, Pa-C, PA-C
Physician Assistant — Payments: $1,627
Physician Assistant $1,627
Mr. Dwight Birkley, Pa-C, PA-C
Physician Assistant — Payments: $654.76
Physician Assistant $654.76
Ms. Sara Karpuk, Pa-C, PA-C
Physician Assistant — Payments: $364.46
Physician Assistant $364.46
Teresa Croft, Pa-C, PA-C
Physician Assistant — Payments: $334.25
Physician Assistant $334.25
Michaela Radtke
Physician Assistant — Payments: $164.69
Physician Assistant $164.69